LU91005I2 - Dibotermine alfa - Google Patents

Dibotermine alfa

Info

Publication number
LU91005I2
LU91005I2 LU91005C LU91005C LU91005I2 LU 91005 I2 LU91005 I2 LU 91005I2 LU 91005 C LU91005 C LU 91005C LU 91005 C LU91005 C LU 91005C LU 91005 I2 LU91005 I2 LU 91005I2
Authority
LU
Luxembourg
Prior art keywords
dibotermine
alfa
bone
research
factors
Prior art date
Application number
LU91005C
Other languages
English (en)
Original Assignee
Inst Genetics Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/031,346 external-priority patent/US4877864A/en
Application filed by Inst Genetics Llc filed Critical Inst Genetics Llc
Publication of LU91005I2 publication Critical patent/LU91005I2/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/51—Bone morphogenetic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/043—Mixtures of macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/227—Other specific proteins or polypeptides not covered by A61L27/222, A61L27/225 or A61L27/24
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Surgery (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Indole Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Photoreceptors In Electrophotography (AREA)
  • Electrochromic Elements, Electrophoresis, Or Variable Reflection Or Absorption Elements (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
LU91005C 1986-07-01 2003-01-29 Dibotermine alfa LU91005I2 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US88077686A 1986-07-01 1986-07-01
US94333286A 1986-12-17 1986-12-17
US2828587A 1987-03-20 1987-03-20
US07/031,346 US4877864A (en) 1987-03-26 1987-03-26 Osteoinductive factors
PCT/US1987/001537 WO1988000205A1 (fr) 1986-07-01 1987-06-30 Nouvelles compositions osteoinductives

Publications (1)

Publication Number Publication Date
LU91005I2 true LU91005I2 (en) 2003-03-31

Family

ID=27487661

Family Applications (1)

Application Number Title Priority Date Filing Date
LU91005C LU91005I2 (en) 1986-07-01 2003-01-29 Dibotermine alfa

Country Status (18)

Country Link
EP (3) EP1254956B1 (fr)
JP (3) JP2713715B2 (fr)
AT (3) ATE234921T1 (fr)
AU (1) AU613314B2 (fr)
CA (1) CA1341212C (fr)
DE (4) DE3751887T2 (fr)
DK (2) DK172275B1 (fr)
ES (1) ES2007625A6 (fr)
GR (1) GR871028B (fr)
IE (1) IE75881B1 (fr)
IL (1) IL83003A (fr)
LU (1) LU91005I2 (fr)
MX (1) MX170919B (fr)
MY (1) MY102505A (fr)
NL (1) NL300116I2 (fr)
NZ (1) NZ220894A (fr)
PT (1) PT85225B (fr)
WO (1) WO1988000205A1 (fr)

Families Citing this family (125)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6150328A (en) * 1986-07-01 2000-11-21 Genetics Institute, Inc. BMP products
IL83003A (en) * 1986-07-01 1995-07-31 Genetics Inst Factors that soak bone formation
US5106748A (en) * 1986-07-01 1992-04-21 Genetics Institute, Inc. Dna sequences encoding 5 proteins
US6020313A (en) * 1987-10-09 2000-02-01 University Of Kansas Method for inducing bone formation using an extract of human osteosarcoma cell line SAOS-2
US5035901A (en) * 1987-10-09 1991-07-30 University Of Kansas Bone inducing agent from a human osteosarcoma cell line
US5324819A (en) * 1988-04-08 1994-06-28 Stryker Corporation Osteogenic proteins
US6586388B2 (en) 1988-04-08 2003-07-01 Stryker Corporation Method of using recombinant osteogenic protein to repair bone or cartilage defects
US4968590A (en) * 1988-04-08 1990-11-06 Stryker Corporation Osteogenic proteins and polypeptides
US5162114A (en) * 1989-02-23 1992-11-10 Stryker Corporation Bone collagen matrix for xenogenic implants
US5670336A (en) * 1988-04-08 1997-09-23 Stryker Corporation Method for recombinant production of osteogenic protein
US5258494A (en) 1988-04-08 1993-11-02 Stryker Corporation Osteogenic proteins
US5354557A (en) * 1988-04-08 1994-10-11 Stryker Corporation Osteogenic devices
WO1989009787A2 (fr) * 1988-04-08 1989-10-19 Creative Biomolecules, Inc. Dispositifs osteogeniques
US5108753A (en) * 1988-04-08 1992-04-28 Creative Biomolecules Osteogenic devices
US5344654A (en) * 1988-04-08 1994-09-06 Stryker Corporation Prosthetic devices having enhanced osteogenic properties
US4975526A (en) * 1989-02-23 1990-12-04 Creative Biomolecules, Inc. Bone collagen matrix for zenogenic implants
JPH03503649A (ja) * 1988-04-08 1991-08-15 ジェネティックス・インスティテュート・インコーポレイテッド 硬骨および軟骨誘導組成物
US5266683A (en) * 1988-04-08 1993-11-30 Stryker Corporation Osteogenic proteins
US5250302A (en) * 1988-04-08 1993-10-05 Stryker Corporation Osteogenic devices
US6919308B2 (en) 1988-04-08 2005-07-19 Stryker Corporation Osteogenic devices
US5106626A (en) * 1988-10-11 1992-04-21 International Genetic Engineering, Inc. Osteogenic factors
US5284756A (en) * 1988-10-11 1994-02-08 Lynn Grinna Heterodimeric osteogenic factor
US4915301A (en) * 1988-11-15 1990-04-10 International Flavors & Fragrances, Inc. Container with sorbent member and microporous membrane for dispensing vapor from volatile liquid
ATE162223T1 (de) * 1989-03-28 1998-01-15 Genetics Inst Osteoinduktive zusammensetzungen
PT94241A (pt) * 1989-06-02 1991-02-08 Chiron Corp Processo para a preparacao de factor calcificacao ossea e de composicoes farmaceuticas que os contem
CA2020729A1 (fr) * 1989-07-19 1991-01-20 Michael C. Kiefer Proteine morphogenetique des os
CA2064878A1 (fr) * 1989-08-21 1991-02-22 Hanne Bentz Proteine specifique des os
DE69027961T2 (de) * 1989-09-06 1997-01-09 Takeda Chemical Industries Ltd Protein, DNA und ihre Verwendung
CA2042577A1 (fr) * 1989-10-17 1991-04-18 Hermann Oppermann Dispositifs osteogeniques
US5168050A (en) * 1990-05-24 1992-12-01 Genentech, Inc. Mammalian expression of the bone morphogenetic protein-2b using bmp2a/bmp2b fusion
US5645591A (en) * 1990-05-29 1997-07-08 Stryker Corporation Synthetic bone matrix
US5364839A (en) * 1990-06-18 1994-11-15 Genetics Institute, Inc. Osteoinductive pharmaceutical formulations
WO1992005199A1 (fr) * 1990-09-26 1992-04-02 Genetics Institute, Inc. Derives bmp-5
US5206023A (en) * 1991-01-31 1993-04-27 Robert F. Shaw Method and compositions for the treatment and repair of defects or lesions in cartilage
CA2363965C (fr) 1991-03-11 2010-05-18 Curis, Inc. Morphogenese induite par des proteines
US7056882B2 (en) 1991-03-11 2006-06-06 Curis, Inc. Treatment to prevent loss of and/or increase bone mass in metabolic bone diseases
US5652337A (en) * 1991-03-11 1997-07-29 Creative Biomolecules, Inc. OP-3-induced morphogenesis
US6077823A (en) * 1991-03-11 2000-06-20 Creative Biomolecules, Inc. Method for reducing tissue damage associated with ischemia-reperfusion or hypoxia injury
US6090776A (en) * 1991-03-11 2000-07-18 Creative Bio Molecules, Inc. Morphogen treatment of organ implants
US6495513B1 (en) 1991-03-11 2002-12-17 Curis, Inc. Morphogen-enhanced survival and repair of neural cells
US5739107A (en) 1991-03-11 1998-04-14 Creative Biomolecules, Inc. Morphogen treatment of gastrointestinal ulcers
US6800603B2 (en) 1991-03-11 2004-10-05 Curis, Inc. Morphogen-induced neural cell adhesion
US5656593A (en) * 1991-03-11 1997-08-12 Creative Biomolecules, Inc. Morphogen induced periodontal tissue regeneration
US5972884A (en) * 1991-03-11 1999-10-26 Creative Biomolecules, Inc. Morphogen treatment of gastrointestinal ulcers
US5849686A (en) * 1991-03-11 1998-12-15 Creative Biomolecules, Inc. Morphogen-induced liver regeneration
US5674844A (en) * 1991-03-11 1997-10-07 Creative Biomolecules, Inc. Treatment to prevent loss of and/or increase bone mass in metabolic bone diseases
US5652118A (en) * 1991-03-11 1997-07-29 Creative Biomolecules, Inc. Nucleic acid encoding a novel morphogenic protein, OP-3
US5318898A (en) * 1991-04-02 1994-06-07 Genetics Institute, Inc. Production of recombinant bone-inducing proteins
US5118667A (en) * 1991-05-03 1992-06-02 Celtrix Pharmaceuticals, Inc. Bone growth factors and inhibitors of bone resorption for promoting bone formation
AU662155B2 (en) 1991-05-10 1995-08-24 Celtrix Pharmaceuticals, Inc. Targeted delivery of bone growth factors
DE69213739T2 (de) * 1991-06-21 1997-02-20 Genetics Inst Osteogene proteine enthaltende arzneimittel
US6022853A (en) * 1991-08-30 2000-02-08 Creative Biomolecules, Inc. Morphogen-enriched dietary composition
US5270300A (en) * 1991-09-06 1993-12-14 Robert Francis Shaw Methods and compositions for the treatment and repair of defects or lesions in cartilage or bone
WO1993009229A1 (fr) 1991-11-04 1993-05-13 Genetics Institute, Inc. Proteines heterodimeres morphogenetiques d'os de recombinaison, compositions et procedes d'utilisation
CZ287715B6 (en) * 1992-02-12 2001-01-17 Bioph Biotech Entw Pharm Gmbh DNA sequence, recombinant DNA molecule containing thereof, process for preparing protein from the group of TGF-beta substances, pharmaceutical preparation containing such protein, antibody or fragment thereof and its use
IL106278A0 (en) * 1992-07-13 1993-11-15 Sumitomo Metal Ind Bone formation-inducing protein
EP0665739B1 (fr) * 1992-09-15 1999-08-04 Creative Biomolecules, Inc. Regeneration tissulaire periodontique induite par des morphogenes
ATE182778T1 (de) * 1992-09-15 1999-08-15 Creative Biomolecules Inc Durch morphogen induzierte periodontolgeweberegeneration
ATE258984T1 (de) * 1993-05-12 2004-02-15 Inst Genetics Llc Bmp-11 zusammensetzungen
US6333168B1 (en) 1993-05-20 2001-12-25 The Trustees Of Columbia University In The City Of New York Cloning, expression and uses of dorsalin-1
US5385887A (en) * 1993-09-10 1995-01-31 Genetics Institute, Inc. Formulations for delivery of osteogenic proteins
US6291206B1 (en) 1993-09-17 2001-09-18 Genetics Institute, Inc. BMP receptor proteins
US5906827A (en) * 1994-06-03 1999-05-25 Creative Biomolecules, Inc. Matrix for the manufacture of autogenous replacement body parts
KR100440645B1 (ko) * 1995-06-05 2004-09-18 뉴욕 쏘사이어티 포 더 릴리프 어브 더 럽쳐드 앤드 크리플드 메인테이닝 더 하스피틀 포 스페셜 설져리 결합조직부착의치료및치유를위한방법및조성물
KR19990036272A (ko) * 1995-08-08 1999-05-25 사우코넨 주시 제이 재조합 ｃ-프로테나제와 이의 공정, 제조방법 및 이의 용도
US5807981A (en) * 1995-12-13 1998-09-15 Fibrogen Inc. Peptides which are cleaved by C-proteinase
EP0894004B2 (fr) 1996-03-22 2007-02-21 Curis, Inc. Procede pour favoriser la recuperation fonctionnelle de la coordination motrice, de la parole ou de la perception sensorielle a la suite d'une ischemie ou d'un traumatisme du systeme nerveux central
US6498142B1 (en) 1996-05-06 2002-12-24 Curis, Inc. Morphogen treatment for chronic renal failure
BR9713130A (pt) * 1996-11-22 2000-02-08 Akzo Nobel Nv Região promotora de bmp-4 e seus fragmentos, vetor compreendendo uma região promotora de bmp-4 ou seus fragmentos, célula hospedeira, processo para a identificação de agentes terapêuticos para a prevenção e/ou tratamento da osteoporose, e, uso de ici 164384.
EP1350525A3 (fr) * 1997-02-07 2003-12-10 Stryker Corporation Dispositif ostéogenique sans matrice, implants et méthodes d'utilisation associées
US7041641B2 (en) 1997-03-20 2006-05-09 Stryker Corporation Osteogenic devices and methods of use thereof for repair of endochondral bone and osteochondral defects
US20010016646A1 (en) 1998-03-20 2001-08-23 David C. Rueger Osteogenic devices and methods of use thereof for repair of endochondral bone, osteochondral and chondral defects
CA2289123A1 (fr) 1997-05-05 1998-11-12 Creative Biomolecules, Inc. Therapies contre l'insuffisance renale aigue
WO1998054572A1 (fr) 1997-05-30 1998-12-03 Creative Biomolecules, Inc. Procedes pour evaluer la morphogenese des tissus et leur activite
US6391311B1 (en) 1998-03-17 2002-05-21 Genentech, Inc. Polypeptides having homology to vascular endothelial cell growth factor and bone morphogenetic protein 1
DK2016951T3 (da) 1998-03-17 2012-09-24 Genentech Inc VEGF- og BMP1-homologe polypeptider
US7147839B2 (en) 1998-05-29 2006-12-12 Curis, Inc. Methods for evaluating tissue morphogenesis and activity
EP1094829B8 (fr) 1998-07-13 2004-09-22 University Of Southern California Procedes permettant d'accelerer la reparation et la croissance des os et des cartilages
US6916783B2 (en) 1998-07-13 2005-07-12 University Of Southern California Methods for accelerating bone and cartilage growth and repair
US6958149B2 (en) 1998-10-06 2005-10-25 Stryker Corporation Repair of larynx, trachea, and other fibrocartilaginous tissues
US7572440B2 (en) 1999-07-30 2009-08-11 Stryker Corporation Method for repairing a defect in an intervertebral disc
WO2000020559A1 (fr) 1998-10-06 2000-04-13 Rush-Presbyterian-St. Luke's Medical Center Procede de traitement par chimionucleolyse
JP3786533B2 (ja) 1998-11-12 2006-06-14 善彦 西村 ペプチド及び骨形成促進剤
JP2002535378A (ja) * 1999-02-01 2002-10-22 ジェネティックス・インスチチュート・インコーポレーテッド 関節軟骨の治癒および修復のための方法および組成物
DE19906096A1 (de) 1999-02-13 2000-08-17 Walter Sebald Protein mit einem Heparin-bindenden Epitop
WO2001016323A2 (fr) * 1999-09-01 2001-03-08 Subsidiary N0.3, Inc. Compositions et procedes d'inhibition de l'infection due au virus de l'immunodeficience humaine a l'aide de genes cellulaires humains a regulation negative
AU771546B2 (en) * 1999-09-01 2004-03-25 Ppd Development, Lp Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes
AU6865100A (en) * 1999-09-02 2001-04-10 Mitsubishi Pharma Corporation Osteogenesis promoting agents
JP3910536B2 (ja) * 2000-12-28 2007-04-25 塩野義製薬株式会社 新規ポリペプチドおよびそのｄｎａ
TWI329129B (en) 2001-02-08 2010-08-21 Wyeth Corp Modified and stabilized gdf propeptides and uses thereof
US7160725B2 (en) 2001-11-13 2007-01-09 Curis, Inc. Hedgehog signaling promotes the formation of three dimensional cartilage matrices
WO2003043673A1 (fr) 2001-11-19 2003-05-30 Scil Technology Gmbh Dispositif dote de proprietes osteoinductives et osteoconductrices
US8067557B2 (en) 2002-03-28 2011-11-29 The Trustees Of The University Of Pennsylvania OCL-2A3 compositions and uses thereof
US7160994B2 (en) 2002-03-28 2007-01-09 Trustees Of The University Of Pennsylvania Osteoclast-specific genes and proteins and uses thereof
ES2260685T3 (es) 2002-09-10 2006-11-01 Scil Technology Gmbh Implante metalico recubierto, a una concentracion de oxigeno reducida, con proteina osteoinductora.
CA2537735C (fr) 2003-09-12 2018-07-24 Wyeth Barres solides et pates de phosphate de calcium injectables pour la delivrance de proteines osteogeniques
EP1701729B1 (fr) 2003-12-31 2018-05-02 Warsaw Orthopedic, Inc. Compositions de matrice osseuse ameliorees et methodes associees
US8734525B2 (en) 2003-12-31 2014-05-27 Warsaw Orthopedic, Inc. Osteoinductive demineralized cancellous bone
EP1571159A1 (fr) * 2004-03-04 2005-09-07 Bayerische Julius-Maximilians-Universität Würzburg Mutéine d' une protéine morphogénétique osseuse et son utilisation
ATE478008T1 (de) 2004-03-10 2010-09-15 Scil Technology Gmbh Überzogene implantate, ihre herstellung und verwendung davon
JP5201987B2 (ja) 2004-05-25 2013-06-05 ストライカー コーポレイション 軟骨欠損を処置するための、形態形成タンパク質の使用
US8506646B2 (en) 2005-04-29 2013-08-13 Warsaw Orthopedic, Inc. Multi-purpose medical implant devices
WO2007053850A2 (fr) 2005-11-01 2007-05-10 Osteotech, Inc. Compositions de matrice d’os et méthodes correspondantes
US20090298761A1 (en) 2006-05-17 2009-12-03 Donald Engelman Methods of treating cartilage defects using a soluble morphogenic protein complex
BRPI0716680A2 (pt) 2006-11-02 2013-09-24 Daniel J Capon "composto, multÍmero, composiÇço, mÉtodo de afetar a atividade de um alvo, complexo, processo de produÇço do composto, mÉtodo de produÇço de um extensço de aminoÁcidos consecutivos, processo de produÇço de uma extensço de aminoacidos consecutivos , processo para a produÇço de um composto , mÉtodo de produÇço de uma proteina e polipeptÍdeo"
AU2007234612B2 (en) 2006-12-14 2013-06-27 Johnson & Johnson Regenerative Therapeutics, Llc Protein stabilization formulations
US20100184659A1 (en) 2006-12-21 2010-07-22 Warren Jaworowicz Sustained-Release Formulations Comprising Crystals, Macromolecular Gels, and Particulate Suspensions of Biologic Agents
EP2167147B1 (fr) 2007-06-15 2017-03-29 Warsaw Orthopedic, Inc. Compositions de matrice osseuse et méthodes
US9554920B2 (en) 2007-06-15 2017-01-31 Warsaw Orthopedic, Inc. Bone matrix compositions having nanoscale textured surfaces
US7678764B2 (en) 2007-06-29 2010-03-16 Johnson & Johnson Regenerative Therapeutics, Llc Protein formulations for use at elevated temperatures
US9492278B2 (en) 2007-07-10 2016-11-15 Warsaw Orthopedic, Inc. Delivery system
JP5323832B2 (ja) 2007-08-07 2013-10-23 アドバンスト・テクノロジーズ・アンド・リジェネレイティブ・メディスン・エルエルシー 酸性水溶液中にｇｄｆ−５を含むタンパク質製剤
CA2718592A1 (fr) 2008-02-13 2009-08-20 Keith Hruska Procede de traitement de la sclerose vasculaire
JP5599778B2 (ja) 2008-04-14 2014-10-01 デピュイ・シンセス・プロダクツ・エルエルシー 液体緩衝ｇｄｆ−５製剤
US9011537B2 (en) 2009-02-12 2015-04-21 Warsaw Orthopedic, Inc. Delivery system cartridge
US20100204123A1 (en) 2009-02-12 2010-08-12 Mary Elizabeth Pecquet Goad Peripheral Administration of Proteins Including TGF-beta Superfamily Members for Treatment of Systemic Disorders and Disease
JP5819734B2 (ja) 2009-02-12 2015-11-24 ストライカー コーポレイションＳｔｒｙｋｅｒ Ｃｏｒｐｏｒａｔｉｏｎ ＴＧＦ−βスーパーファミリーメンバー含有タンパク質の最小に侵襲性の全身送達のための組成物および方法
EP2406281B1 (fr) * 2009-03-12 2016-02-17 Haase Investments UG Variants de la protéine morphogénétique osseuse 2 (bmp2) avec une sensibilité réduite aux antagonistes des bmp
WO2010110974A1 (fr) 2009-03-24 2010-09-30 Stryker Corporation Procédés et compositions pour l'ingénierie tissulaire
US20110002897A1 (en) 2009-06-11 2011-01-06 Burnham Institute For Medical Research Directed differentiation of stem cells
SG177467A1 (en) * 2009-07-23 2012-02-28 Agency Science Tech & Res Pre-natal mesenchymal stem cells
WO2011031856A1 (fr) 2009-09-09 2011-03-17 Stryker Corporation Bmp-7 à utiliser dans le traitement de la douleur induite par les lésions et les maladies d'articulation
EP2352750B1 (fr) 2009-09-17 2012-06-13 Stryker Corporation Tampons utilisés pour la régulation du ph des protéines morphogénétiques osseuses
WO2011087768A1 (fr) 2009-12-22 2011-07-21 Stryker Corporation Variants de la bmp-7 dotés d'une immunogénicité réduite
NZ746109A (en) 2016-12-30 2022-12-23 Biogend Therapeutics Co Ltd Recombinant polypeptides and nucleic acid molecules, compositions, and methods of making and uses thereof

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4455256A (en) * 1981-05-05 1984-06-19 The Regents Of The University Of California Bone morphogenetic protein
US4619989A (en) * 1981-05-05 1986-10-28 The Regents Of The University Of Cal. Bone morphogenetic protein composition
US4419446A (en) 1980-12-31 1983-12-06 The United States Of America As Represented By The Department Of Health And Human Services Recombinant DNA process utilizing a papilloma virus DNA as a vector
US4434094A (en) * 1983-04-12 1984-02-28 Collagen Corporation Partially purified osteogenic factor and process for preparing same from demineralized bone
US4588684A (en) 1983-04-26 1986-05-13 Chiron Corporation a-Factor and its processing signals
CA1229789A (fr) * 1983-06-06 1987-12-01 David Baylink Polypeptides stimulant la croissance du tissu osseaux
US4795804A (en) * 1983-08-16 1989-01-03 The Regents Of The University Of California Bone morphogenetic agents
NZ210699A (en) * 1984-01-04 1989-06-28 Int Genetic Eng Isolation of an osteogenic protein of the p3 immunologically related family
ZA848495B (en) 1984-01-31 1985-09-25 Idaho Res Found Production of polypeptides in insect cells
US4608199A (en) * 1984-03-20 1986-08-26 Arnold Caplan Bone protein purification process
IL75725A (en) 1984-07-06 1993-02-21 Sandoz Ag Recombinant human gm-csf
EP0169016B2 (fr) 1984-07-16 2004-04-28 Celtrix Pharmaceuticals, Inc. Facteur polypeptidique issu des os induisant le cartilage
ATE78515T1 (de) 1984-10-05 1992-08-15 Genentech Inc Dna, zellkulturen und verfahren zur sekretion von heterologen proteinen und periplasmische proteinrueckgewinnung.
US4563350A (en) * 1984-10-24 1986-01-07 Collagen Corporation Inductive collagen based bone repair preparations
IL83003A (en) * 1986-07-01 1995-07-31 Genetics Inst Factors that soak bone formation

Also Published As

Publication number Publication date
MY102505A (en) 1992-07-31
ES2007625A6 (es) 1989-07-01
PT85225A (en) 1987-08-01
ATE141928T1 (de) 1996-09-15
JP3093682B2 (ja) 2000-10-03
ATE234921T1 (de) 2003-04-15
DK106288A (da) 1988-04-28
DK172275B1 (da) 1998-02-16
WO1988000205A1 (fr) 1988-01-14
JP2729222B2 (ja) 1998-03-18
DK172503B1 (da) 1998-10-26
JPH1070989A (ja) 1998-03-17
DE3751887D1 (de) 1996-10-02
EP0688869B1 (fr) 2003-03-19
MX170919B (es) 1993-09-22
EP0313578A1 (fr) 1989-05-03
DK53497A (da) 1997-05-09
IL83003A (en) 1995-07-31
NL300116I2 (nl) 2003-06-02
IE75881B1 (en) 1997-09-24
IL83003A0 (en) 1987-12-20
EP1254956A2 (fr) 2002-11-06
EP0688869A1 (fr) 1995-12-27
NZ220894A (en) 1990-05-28
DE3751887T2 (de) 1997-03-06
CA1341212C (fr) 2001-04-10
IE970378L (en) 1988-01-01
JPH02500241A (ja) 1990-02-01
EP1254956B1 (fr) 2008-12-31
EP0313578B1 (fr) 1996-08-28
DE10399007I2 (de) 2006-03-16
GR871028B (fr) 1988-01-11
EP0313578A4 (en) 1990-10-03
AU613314B2 (en) 1991-08-01
DE10399007I1 (de) 2003-07-31
JPH06298800A (ja) 1994-10-25
DE3752364T2 (de) 2004-03-04
JP2713715B2 (ja) 1998-02-16
DE3752393D1 (de) 2009-02-12
DK106288D0 (da) 1988-02-29
AU7783587A (en) 1988-01-29
IE871739L (en) 1988-01-01
EP1254956A3 (fr) 2002-11-13
ATE419349T1 (de) 2009-01-15
NL300116I1 (nl) 2003-05-01
PT85225B (pt) 1990-03-30
DE3752364D1 (de) 2003-04-24

Similar Documents

Publication Publication Date Title
LU91005I2 (en) Dibotermine alfa
EP0484401A4 (en) Production of vascular endothelial cell growth factor
GR880300077T1 (en) Galanthamine or analogues thereof for treating alzheimer's disease
IL91412A0 (en) Process and solution for the lyophilization of blood cells
GB2211192B (en) Composition and process for the treatment and care of the hair
EP0217004A3 (en) Process for controlling the cis-transconfiguration of the double bonds in polyalkenamers
EP0294028A3 (en) Fluoxetine useful for the treatment of diabetes
ZA886273B (en) Novel hiv proteins and peptides useful in the diagnosis,prophylaxis or therapy of aids
BG49719A3 (en) Method for preparing of variants chirudine and their use
EP0249094A3 (en) Method and plant for the treatment of laminated glass
DE3572441D1 (en) Use of interferon gamma (ifn-gamma) for the production of preparations for treating rheumatic diseases
GB2203645B (en) Improvements in the treatment of hair
NZ224348A (en) Tanning composition with al and ti
ATE94903T1 (de) Analoge des porcin-wachstumshormones.
PT81774A (en) Improvememnts relating to the method for treating leather and similar products
HUT40312A (en) Process for producing protein concentrates and nutriments containing bioactive materials
EP0288901A3 (en) Recombinant human glutathione peroxidase, process for preparing the same and dna coding the same